08 / HEALTHCARE 4.0 ESSENTIAL
Not a hospital, not a hospice, not a spa —
a new place for recovery
Hospital-linked, resort-based, GRBM-powered advanced metabolic supportive care. On the premise of a clinician's eligibility assessment, it gives clients with serious or complex health conditions a recovery environment and metabolome-based supportive care, while building clinical observation data.
In plain words
HIGH applies GRBM Bio Healthcare 4.0 to clients with serious or complex health conditions as a hospital-linked advanced metabolic supportive-care program. It is a Life Re:Design model combining a natural resort environment, hospital cooperation, GRBM medi-food, biomarker monitoring, clinical observation data and the potential for research publication.
This service does not replace hospital treatment. It is an advanced supportive-care platform that cooperates with hospitals to manage nutrition, the recovery environment, the gut microbiome, metabolic burden, quality of life, psychological stability and the experience of recovery during a stay. Its potential was first confirmed in hundreds of the company's own direct applications, and LOW, MIDDLE and HOLON were designed on top of it.
I believe that the moment the digestive organs start working, human cells switch to a "Working Mode" and their self-recovery slows sharply. The heart of HIGH is therefore to guide self-recovery through the cells' "Resting Mode", supplying the bio-materials they need while the digestive organs rest.
A NEW CATEGORY
Filling the gap
between existing models
| Existing model | Limit | What HIGH does differently |
|---|---|---|
| Hospital admission | Treatment-centred, limited recovery environment | Hospital link + natural recovery environment |
| Hospice | Focused on end-of-life care | For seriously ill clients with recovery potential |
| Wellness resort | Weak medical response | Medical partnership and biomarker monitoring |
| Functional-medicine clinic | Tests and supplements | Stay-based GRBM protocol and specialist care |
| Medical tourism | Procedure-centred | Long-term recovery, metabolic support and data |
| Premium care home | Daily-living care | Personalized GRBM metabolome application |
| Clinical trial centre | Research-centred, weak client experience | Research combined with a premium care experience |
The World Health Organization notes that about 56.8 million people need palliative and supportive care each year, yet only about 14% receive it. Company materials see three currents — palliative and supportive care, medical tourism, and home and remote care — widening the space where HIGH stands.
SIX MODULES
The six modules
that make up HIGH
-
01
Hospital-linked medical governance
Clinician eligibility assessment, information sharing with attending and partner hospitals, emergency transfer protocol, review of conflicts between drug and treatment schedules and GRBM intake, infection control, resident nurses or specialists, medical-data protection
-
02
Personalized medi-food protocol
GRBM MFK, MFS, MFB, MPM, GRBM and PANAX GRBM are combined according to ability to eat, digestive burden, weight, blood and nutrition markers, microbiome, sleep and recovery goals
-
03
Biomarker and human application data
Blood chemistry, liver and kidney function, inflammation and lipid markers, total protein and albumin, vitamins, body composition, sleep and stress, gut microbiome and metabolites, quality of life, food intake and weight, daily activity — before, during and after the stay
-
04
Resort-based recovery environment
Recovery spaces with natural views, private or family rooms, GRBM thawing and preparation, bath and heat care, gentle exercise, breathing and meditation, nursing and emergency response, a data room and family counselling
-
05
MHM-PI research option
Considered only within research that meets patient consent, clinician judgement, IRB approval, applicable law and non-clinical, clinical, GMP and approval procedures
-
06
Publication and evidence strategy
Individual case observations → retrospective case series → prospective observational registry → IRB-approved pilot → controlled application study → disease-specific clinical trial
Because intake of medicines as well as foods may be limited during HIGH in consultation with clinicians, metabolic disturbance and weight loss can appear for about 2–10 days. The body has then been observed to enter a recovered state through metabolic realignment. Remote management is possible once the conditions are met.
Not "it got better",
but data before, during and after
HIGH is designed as a structured human application registry — the most important clinical credibility layer in the whole service.
PROGRAMS
Three programs
and integrated family care
| Program | For | Duration | Components |
|---|---|---|---|
| Advanced Recovery | Clients needing a recovery environment after existing treatment | 2–4 weeks | Personalized GRBM, daily condition checks, medical consultation once or twice a week, heated massage, sleep recovery, gentle exercise, blood-test comparison, home-care package |
| Complex Metabolic Support | Clients with chronic or complex conditions | 4–8 weeks | Pre-admission medical eligibility review, blood and microbiome tests, protocol including PANAX GRBM, accompanying specialists and nutritionists, family counselling, weekly reports, 12-week post-program subscription |
| Clinical Observation | Clients who consent to observational research | 4–12 weeks | IRB-reviewable structure, informed consent, standardized biomarker panel, diet, sleep and activity records, quality-of-life questionnaires, joint analysis with research institutions and hospitals, conference and journal publication |
| VIP Family Integrated Care | Families and international clients | Tailored | Dedicated team, family stays, international client support |
- Primary clientsPeople seeking a recovery environment after treatment, families of seriously ill patients, domestic and international clients wanting nature-based supportive care
- Secondary clientsRecovery after cancer treatment, complex illness, frail older clients, and people needing care foods, metabolic nutrition or microbiome management — all with clinician consent
- ExcludedPeople close to death; acute infection, bleeding or organ failure; those needing ICU-level care; those whose clinician forbids a stay-based program; those unable to take GRBM; those without capacity to consent or sufficient legal proxy consent
Read moreCloseStep-by-step evidence strategy, expansion model, risks and responses, and observed distinctive reactions
Stages of research and evidence
-
01
Case Documentation
Record condition, intake protocol, duration, test values, changes in quality of life, food intake, weight and sleep, side effects, clinician opinion and caregiver observation
-
02
Observational Registry
Accumulate client groups — post-cancer recovery, frail elderly, complex chronic illness, microbiome imbalance, poor nutrition — on the same indicators
-
03
Academic Publication
Present prospective observational registries and early human application observations at conferences and in journals
-
04
IRB-Approved Study
Convert to IRB-approved research once enough data has accumulated
-
05
MHM-PI Candidate Pathway
Non-clinical toxicity, cell efficacy, GMP manufacturing, clinical trial plans, indication-specific development and technology transfer or co-development on a separate track
Expansion model
After validation at a Korean flagship, HIGH expands through hospital–resort partnerships (Elan Vital BIO: products, protocols, data systems and training; hospitals: medical assessment, testing, emergency response and clinical advice; resorts: lodging, meals and recovery spaces; research institutions: analysis and publication), and then into a Global VIP Medical Wellness Network in premium medical-tourism regions such as Jeju, Seoul, Tokyo, Singapore, Dubai and Switzerland, with product supply, hospital and resort partners, frozen logistics and data servers matched to each country's rules.
Risks and responses
| Risk | Response |
|---|---|
| Mistaken for medical practice | Formal cooperation with medical institutions, no claims of treating disease, the purpose stated clearly as supportive care and quality-of-life improvement |
| Safety of seriously ill clients | Medical eligibility assessment before every admission, emergency response protocol |
| Data protection | Data security system, removal of identifying information in case presentations |
| MHM-PI regulation | A separate research and clinical track; IRB, GMP, non-clinical and clinical procedures |
| Reputation | Stronger consent and explanation; outcomes described only as "observed, monitored, supported" |
Distinctive reactions observed
During GRBM application, strong pulsation of the thymus and abdominal aorta (lasting tens of minutes to several hours), long sleep and the discharge of large amounts of cellular waste have been observed. I interpret this as a signal that the thymus's immune-education function is temporarily reactivated, T-cell information is updated and a Treg-centred immune balance is realigned. A detailed interpretation is on Observation Models.
HIGH Level Service does not replace licensed medical treatment; it is a complementary Bio Supportive Care platform that provides a recovery environment and metabolic supportive care in cooperation with medical institutions. Observed reactions are the developer's (Wooyoung Nam's) observation cases and research hypotheses, not independent medical claims. Pricing and unit economics are provided after an NDA.
PARTNERSHIP · INVESTMENT
The world's first true eco-bio platform technology —
we are looking for the one partner
After signing an NDA you can review the materials, then verify the original records and the process in person during on-site due diligence in Uljin, Gyeongsangbuk-do, Korea.